Sunshine Biopharma warrant (SBFMW) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 99 130 sessions, October 17, 2025 to October 19, 2026
- Largest daily move
- +123.6% close of June 23, 2026
- 1-year change
- -91.7% closing prices, October 17, 2025 to October 19, 2026
- 1-month change
- -53.7% closing prices, September 18, 2026 to October 19, 2026
Company Description
Sunshine Biopharma warrant (NASDAQ: SBFMW) is classified in the pharmaceutical preparations industry.
SBFMW has declined 91.7% over the past year. The last closing price was $0.0250.
For FY2025, Sunshine Biopharma warrant reported revenue of $36.3M with net income of -$6.0M. The company operates at a net profit margin of -16.5%.
This page collects what Stock Titan holds for SBFMW, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
Sunshine Biopharma warrant (SBFMW) closed at $0.0250 on October 19, 2026. Over the past 12 months, the price has lost 91.7%.
SBFMW Metrics & Rankings
Price returns through October 19, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Sunshine Biopharma warrant has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 8 with negative movement. Key topics include earnings, private placement, covid-19, buybacks. View all SBFMW news →
SEC Filings
Sunshine Biopharma warrant has filed 10 recent SEC filings, including 4 Form 8-K, 2 Form SCHEDULE 13G, 2 Form S-1, 1 Form SCHEDULE 13G/A. The most recent filing was submitted on October 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SBFMW SEC filings →
Financial Highlights
Sunshine Biopharma warrant generated $36.3M in revenue in FY2025, retaining a 33.8% gross margin, operating income reached -$6.2M (-17.2% operating margin), and net income was -$6.0M, reflecting a -16.5% net profit margin. The company generated -$5.3M in operating cash flow. The current ratio was 4.17, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in Sunshine Biopharma warrant (SBFMW) currently stands at 773 shares. Since October 2025, short interest has decreased by 78.9%.
Days to Cover History
Days to cover for Sunshine Biopharma warrant (SBFMW) currently stands at 1.0 days, down 95.1% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since October 2025, the figure has decreased by 22.5%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
SBFMW Company Profile & Sector Positioning
Sunshine Biopharma warrant (SBFMW) and is listed on the NASDAQ.
Investors comparing SBFMW often look at related companies in the same sector, including Biofrontera Inc. Warrants (BFRIW), CLEVER LEAVES HLDGS WTS (CLVRW), Sunshine Biopharma Inc. (SBFM), InMed Pharmaceuticals Inc. (INM), and AYTU BioPharma, Inc. (AYTU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SBFMW's relative position within its industry.